|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07C 217/62 | |
| A61K 31/135 | |||
| C07C 213/10 | |||
| A61P 13/00 |
| (11) | Number of the document | 1613584 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04725610.2 |
| Date of filing the European patent application | 2004-04-03 | |
| (97) | Date of publication of the European application | 2006-01-11 |
| (45) | Date of publication and mention of the grant of the patent | 2007-11-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2004/003567 |
| Date | 2004-04-03 |
| (87) | Number | WO 2004/089872 |
| Date | 2004-10-21 |
| (30) | Number | Date | Country code |
| 10315917 | 2003-04-08 | DE |
| (72) |
BREITENBACH, Armin, DE
MEESE, Claus, DE
WOLFF, Hans-Michael, DE
DREWS, Roland, DE
|
| (73) |
SCHWARZ PHARMA AG,
Alfred-Nobel-Strasse 10, 40789 Monheim,
DE
|
| (54) | PHARMAZEUTISCHE FORMULIERUNGEN ENTHALTEND HOCHREINE BASEN VON 3,3-DIPHENYLPROPYLAMINMONOESTERN |
| PHARMACEUTICAL FORMULATIONS COMPRISING HIGHLY PURE BASES OF 3,3-DIPHENYL PROPYLAMINE MONOESTERS |